je.st
news
Tag: merck
Merck to Present Phase 3 Data on Investigational Medicines Ertugliflozin and MK-1293 at the 76th Scientific Sessions of the American Diabetes Association
2016-05-12 14:30:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Additional Analyses from the TECOS Cardiovascular Safety Trial of JANUVIA (sitagliptin) Also to Be Presented KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that researchers will present data from clinical trials of its investigational diabetes pipeline, JANUVIA (sitagliptin), and new real-world research in more than 20 scientific data presentations at the 76th Scientific Sessions of the American Diabetes Association (ADA) being held in New Orleans, June 10-14, 2016. Language: English Contact: MerckMedia:Doris Li, 908-246-5701Kristen Drake, 908-236-4223orInvestors:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: the
data
present
american
High-Tech for the Automotive Industry from Merck KGaA, Darmstadt, Germany
2016-05-10 16:07:43| Coatings World Breaking News
Tags: germany
industry
automotive
darmstadt
Merck Announces First-Quarter 2016 Financial Results
2016-05-05 12:45:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. First-Quarter 2016 GAAP EPS was $0.40; First-Quarter Non-GAAP EPS Increased by 5 Percent to $0.89 Company Continues to Expect 2016 Full-Year GAAP EPS to be Between $1.96 and $2.23; Narrows and Raises 2016 Full-Year Non-GAAP EPS to be Between $3.65 and $3.77 First-Quarter 2016 Worldwide Sales Were $9.3 Billion, a Decrease of 1 Percent, Including a 4 Percent Negative Impact from Foreign Exchange Obtained FDA Approval of ZEPATIER in the Treatment of Chronic Hepatitis C Genotypes 1 or 4 Infection Advanced KEYTRUDA Development Program sBLA Accepted for Recurrent or Metastatic Head and Neck Cancer Breakthrough Therapy Designation Granted for Classical Hodgkin Lymphoma KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the first quarter of 2016. Our first quarters performance sets us on a good course for the year, said Kenneth C. Frazier, chairman and chief executive officer, Merck. We remain focused on advancing our pipeline and driving the commercial success of our key launches and inline medicines and vaccines. Financial Summary Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: results
financial
announces
merck
Merck to Present at the Deutsche Bank 41st Annual Health Care Conference
2016-05-04 14:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Adam Schechter, executive vice president and president, Global Human Health, Merck, is scheduled to present at the Deutsche Bank 41st Annual Health Care Conference in Boston on May 5, 2016 at 12:50 p.m. EDT. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036Steven Cragle, 908-740-1801orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: health
care
present
bank
Merck Animal Health receives Nebraska Governors Bioscience Award
2016-04-29 06:00:00| National Hog Farmer
Merck Animal Health is pleased to announce that the Bio Nebraska Life Sciences Association has selected the company as the recipient of the 2016 Governor’s Bioscience Award. The award, which recognizes significant contributions to Nebraska’s bioscience industry and overall economy, is given to an organization that has made a considerable impact on the state through innovation, business creation, investment and leadership. It is the highest honor bestowed by Bio Nebraska and was presented by Gov. Pete Ricketts. read more
Tags: health
award
animal
nebraska
Sites : [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] next »